Biophysical

Callum G Fraser BSc, PhD, FAACB

Callum Fraser graduated from the University of Aberdeen. Following postdoctoral work in the National Research Council of Canada, he returned to Aberdeen as Lecturer in Chemical Pathology in 1970. From 1975, he was Chief Clinical Biochemist at the then new Flinders Medical Centre in South Australia and Senior Lecturer [later Associate Professor] in the Medical School of the Flinders University of South Australia. He returned to Scotland in 1983 and is currently Consultant Clinical Biochemist, NHS Tayside, and Honorary Professor in Pathology and Neuroscience in the University of Dundee. He is lead for the Scottish Bowel Screening Centre Laboratory. Much in demand as a speaker, he has published many book chapters, papers and articles, mainly on setting quality specifications, biological variation, and laboratory aspects of bowel cancer, and has authored two monographs - Interpretation of Clinical Chemistry Laboratory Data and Biological Variation: From Principles to Practice [both translated into Spanish and the latter also into Japanese and Italian]. He has served on many national and international professional bodies, including acting as Chairman of the Education Committee of IFCC, and for the World Health Organization. He has been honored by the Foundation Award and Honorary Membership of the Association of Clinical Biochemists, the Roman Travelling Lectureship of the Australasian Association of Clinical Biochemists, and the IFCC Travelling Lectureship to Kenya and Uganda, and Chile.

Bruce A. Friedman, MD Active Emeritus Professor of Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan

Dr. Friedman is one of the world's leading experts in the area of pathology and laboratory informatics, which is the medical discipline that addresses the storage, retrieval, and publication of information generated in pathology and the hospital clinical laboratories. He is board-certified in both anatomic and clinical pathology and served as a faculty member in the Department of Pathology, University of Michigan Medical School, for 33 years. His affiliation with the Department continues after his retirement as an Active Emeritus Professor. While active in the department, he served as the co-director of Division of Pathology Informatics in the Department and also as the Director of Clinical Support Services, Medical Center Information Technology, for the University of Michigan Health System. He was the founding co-president of the Association for Pathology Informatics. He has served as the director of a yearly conference on pathology informatics for 25 years. For the past for years, this conference, Lab InfoTech Summit, has been presented in Las Vegas under the sponsorship of the Pathology Education Consortium of which he is president. He is the author of a well-known clinical laboratory blog, Lab Soft News. He is also the author of some 90 scientific articles, book chapters and abstracts.

Stanley L. Hazen, MD, PhD Section Head, Preventive Cardiology and Rehabilitation, Director for the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation, Cleveland, Ohio

Dr. Hazen is one of the world's leading specialists in the area of preventive medicine for cardiovascular health, specializing in the care of patients with hyperlipidemia, diabetes and hypertension. He graduated summa cum laude with an undergraduate degree in biochemistry from Washington University in St. Louis, where he received both a medical degree and doctorate in biophysical chemistry and molecular biology. His clinical internship and residency in internal medicine was completed at Barnes-Jewish Hospital in St. Louis, followed by a fellowship in endocrinology, diabetes and metabolism. He is a Board-Certified Diplomate of The American Board of Internal Medicine and The National Board of Medical Examiners, as well as a staff physician in the Departments of Cell Biology and Cardiovascular Medicine. His research interests include understanding the role of inflammation and oxidant stress in the pathogenesis of atherosclerosis and other inflammatory diseases. He is an expert in the biochemistry of leukocyte peroxidases, free radicals and reactive oxygen species and mechanisms of oxidative damage. Widely published in peer-reviewed journals, he is serving a five-year term on the editorial board of The Journal of Biological Chemistry.

Stephen L. Kopecky, MD Associate Professor of Medicine, Mayo Medical School, Consultant, Internal Medicine and Cardiovascular Diseases, Mayo Clinic Rochester, Minnesota

Dr. Kopecky is a respected cardiologist, who specializes in preventing heart disease. A graduate of the University of Texas Health Science Center at Houston, he completed his clinical internship and residency in internal medicine and a fellowship in cardiovascular diseases at the Mayo Graduate School of Medicine in Rochester, Minnesota. After performing intervention procedures to treat heart attacks at the Mayo Clinic for 18 years, Dr. Kopecky turned his attention to finding ways to prevent heart disease. He currently works in the Cardiovascular Health Clinic, the prevention clinic in the Division of Cardiovascular Diseases at the Mayo Clinic, where he is researching the role of inflammation in cardiovascular disease and how lifestyle — including a Mediterranean diet, exercise and proper nutrition — influence the progression of cardiovascular disease. He has authored numerous articles on his research findings, which have been published in peer-reviewed medical journals such as American Heart Journal, American Journal of Cardiology, American Journal of Medicine, Circulation, JAMA and New England Journal of Medicine. Dr. Kopecky is also the recipient of multiple Teacher of the Year awards from the division of Cardiovascular Diseases and the Department of Internal Medicine at the Mayo Medical School.